U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: September 12-18, 2021
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: September 12-18, 2021

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Janet Woodcock, M.D., Acting Commissioner

Event Date: 09/12/2021
Location: Virtual
Subject: Regulatory Affairs Professionals Society (RAPS): Convergence 2021
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, media, and other registered guests

Event Date: 09/15/2021
Location: Virtual
Subject: Trial Updates and Protocols
FDA Participant/Group: PETER STEIN;
Non FDA Participant/Group: Parties involved in Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)

Event Date: 09/17/2021
Location: Virtual
Subject: Hever COVID-19 Follow Up
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, and other invited guests

Event Date: 09/17/2021
Location: Virtual
Subject: Partnership with Food and Drug Administration
FDA Participant/Group: N/A
Non FDA Participant/Group: Klaus Romero, Tim Franson, Wainwright Fishburn (Critical Path Institute);

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 09/15/2021
Location: Virtual
Subject: Society for Women's Health Research (SWHR) Meeting
FDA Participant/Group: N/A
Non FDA Participant/Group: Members of the SWHR Policy Advisory Council

Event Date: 09/17/2021
Location: Virtual
Subject: Listening Session with AdvaMed
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Stakeholders from AdvaMed

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 09/13/2021
Location: Virtual
Subject: 2021 FDA Retail Food Protection Seminar
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Food safety experts from government, academia, and industry

Event Date: 09/14/2021
Location: Virtual
Subject: American Frozen Food Institute Food Safety Forum; Food Safety Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Global research experts, industry professionals, and food safety policy leaders

Event Date: 09/14/2021
Location: Virtual
Subject: Cyclospora Update
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Staff and members of the National Association of State Departments of Agriculture

Event Date: 09/15/2021
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Staff and members of the National Association of State Departments of Agriculture

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 09/15/2021
Location: Virtual
Subject: FDA Virtual Dialogue on Good Regulatory Practices
FDA Participant/Group: LAUREN ROTH, JARILYN DUPONT
Non FDA Participant/Group: Foreign Drug and Food Regulators From Africa, South America, Asia, and Europe

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

Event Date: 09/13/2021
Location: Virtual
Subject: Listening Session with Critical Path Institute on Tangible Impact of Programs
FDA Participant/Group: SHAAVHREE BUCKMAN GARNER; SHAWN BROOKS;
Non FDA Participant/Group: Representatives from Critical Path Institute

Event Date: 09/14/2021
Location: Virtual
Subject: Glaxo-Smith Klein (GSK) Consumer Healthcare Meeting
FDA Participant/Group: THERESA MICHELE; MICHAEL BERNSTEIN; PETER STEIN; JACQUELINE CORRIGAN CURAY; BIC NGUYEN; GRAIL SIPES;
Non FDA Participant/Group: Elizabeth Brewer, Lauren Quinn, Lisa Paley, Michelle Bateson, Vidhu Bansal-Dev (Glaxo-Smith Klein (GSK) Consumer Healthcare);

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 09/12/2021
Location: Virtual
Subject: Regulatory Affairs Professionals Society (RAPS) Convergence 2021; Opening Plenary Session: Celebrating the Profession
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the RAPS Convergence 2021 Meeting

Event Date: 09/13/2021
Location: Virtual
Subject: National Hemophilia Foundation (NHF) State of the Science Research Summit; Plenary: The Evolving Process to Move Rare Disease Therapeutics Through the Regulatory Process
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of NHF State of the Science Research Summit

Event Date: 09/13/2021
Location: Virtual
Subject: Regulatory Affairs Professionals Society (RAPS) Convergence 2021; Health Authority Forum: CBER
FDA Participant/Group: N/A
Non FDA Participant/Group: Attendees of the RAPS Convergence 2021 Meeting

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

Event Date: 09/14/2021
Location: Virtual
Subject: International Medical Device Regulators Forum; Session 1: USA Regulatory Update
FDA Participant/Group: MELISSA TORRES;
Non FDA Participant/Group: Representatives from Medical Device Regulatory Agencies

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

Event Date: 09/17/2021
Location: Virtual
Subject: Quarterly Meeting with Nutrition Consumer and Public Health Stakeholders on Nutriton Issues
FDA Participant/Group: PATRICIA HANSEN; CONRAD CHOINIERE; ROBIN MCKINNON; DOUGLAS BALENTINE; CLAUDINE KAVANAUGH; DAVID GOLDMAN; KARI BARRETT; LAURA CARROLL; LINDSAY HAAKE; CHRISTOPHER WALDROP; JENNIFER DOOREN; JANESIA ROBBS;
Non FDA Participant/Group: Eva Greenthal (Center for Science in the Public Interest (CSPI));

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 09/13/2021
Location: Virtual
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: NEAL BATALLER; JEFFREY GILBERT; MATTHEW LUCIA; REGINA TAN; ANNE NORRIS; LESLIE KENNA; JOHN MUSSMAN; SIOBHAN DELANCEY; JOSHUA HAYES; JULI ANN PUTNAM; CHARLI LONG; ANTONIA MONIQUE SENNETT; AMBER MCCOIG; ERROL STRAIN; HEATHER TATE; PATRICK MCDERMOTT; WILLIAM FLYNN; ASHLEY STEEL; CINDY BURNSTEEL; TIMOTHY SCHELL; NADINE STEINBERG;
Non FDA Participant/Group: Representatives from Keep Antibiotics Working (KAW)

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Acting Chief Counsel

No Significant Event

 

Back to Top